secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOVIE INC. (BIVI)
CIK:        0001580149
Form:       8-K
Filed at:   2022-12-06T23:59:59+00:00
Accession:  0001520138-22-000546
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioVie increases ATM offering capacity from $8.1M to $17.5M under sales agreement
--------------------------------------------------------------------------------

- Filed prospectus supplement on Dec. 6, 2022 to raise maximum aggregate offering from $8.1M to $17.5M.
- Previously issued and sold 1,934,871 shares for net proceeds of approximately $7.4M (after ~$228K in fees).
- Shares sold via Controlled Equity Offering through agents Cantor Fitzgerald & Co. and B. Riley Securities.
- Up to $17.5M in additional shares of Class A common stock may now be sold under the at-the-market program.
- Prospectus supplement filed due to increase in public float since prior supplement dated Sept. 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1580149/000152013822000546/0001520138-22-000546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1580149/000152013822000546/bivi-20221206_8k.htm
  HTML page:      https://secwatch.observer/filing/0001520138-22-000546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer